Literature DB >> 2865645

Cachectin/tumour-necrosis-factor production by cancer patients.

D Aderka, S Fisher, Y Levo, H Holtmann, T Hahn, D Wallach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2865645     DOI： 10.1016/s0140-6736(85)92713-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  20 in total

1.  Serum levels of tumour necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patients.

Authors:  M Maltoni; L Fabbri; O Nanni; E Scarpi; L Pezzi; E Flamini; A Riccobon; S Derni; G Pallotti; D Amadori
Journal:  Support Care Cancer       Date:  1997-03       Impact factor: 3.603

2.  Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.

Authors:  K J Tracey; S Morgello; B Koplin; T J Fahey; J Fox; A Aledo; K R Manogue; A Cerami
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

Review 3.  Are cytokines possible mediators of cancer cachexia?

Authors:  Y Noguchi; T Yoshikawa; A Matsumoto; G Svaninger; J Gelin
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

4.  Production of interleukin-1 and tumour necrosis factor in non-Hodgkin's lymphoma patients.

Authors:  K Jhaver; A De; S Advani; J Nadkarni
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 5.  Pathophysiology of cancer cachexia.

Authors:  U Keller
Journal:  Support Care Cancer       Date:  1993-11       Impact factor: 3.603

6.  Tumor necrosis factor in benign and malign tissue of the kidney.

Authors:  K H Bichler; S Kleinknecht; H J Nelde; W L Strohmaier
Journal:  Urol Res       Date:  1991

7.  Rapid turnover proteins as a prognostic indicator in cancer patients.

Authors:  Y Inoue; R Nezu; H Matsuda; Y Takagi; A Okada
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

8.  Cancer cachexia is regulated by selective targeting of skeletal muscle gene products.

Authors:  Swarnali Acharyya; Katherine J Ladner; Lori L Nelsen; Jeffrey Damrauer; Peter J Reiser; Steven Swoap; Denis C Guttridge
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

9.  The monocyte tumor necrosis factor-alpha production in patients with acute leukemia in complete remission.

Authors:  M Aiso; Y Iizuka; H I Kang; S Sawada; T Ohshima; T Horie
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

Review 10.  Myeloid-derived suppressor cells in cancer cachexia syndrome: a new explanation for an old problem.

Authors:  Robert D Winfield; Matthew J Delano; Kalyan Pande; Philip O Scumpia; Drake Laface; Lyle L Moldawer
Journal:  JPEN J Parenter Enteral Nutr       Date:  2008 Nov-Dec       Impact factor: 4.016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.